2020
DOI: 10.1016/j.yjbinx.2020.100067
|View full text |Cite
|
Sign up to set email alerts
|

A spatial neighborhood methodology for computing and analyzing lymph node carcinoma similarity in precision medicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
3
3
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 32 publications
0
9
0
Order By: Relevance
“…Nevertheless, as can be seen in the model evaluation, the addition of the RFS clusters to other predictive clinical covariates including N-staging, HPV status, and Therapeutic combination improves model performance for both training and testing. Prior work has also effectively leveraged clustering to improve outcome prediction for OPC patients [39][40][41]49], however, none of these works have attempted to use the entire set of radiomic features or Random Survival Forest learning as we have done in this work.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, as can be seen in the model evaluation, the addition of the RFS clusters to other predictive clinical covariates including N-staging, HPV status, and Therapeutic combination improves model performance for both training and testing. Prior work has also effectively leveraged clustering to improve outcome prediction for OPC patients [39][40][41]49], however, none of these works have attempted to use the entire set of radiomic features or Random Survival Forest learning as we have done in this work.…”
Section: Discussionmentioning
confidence: 99%
“…Head and neck cancer, which includes cancers of the larynx, throat, lips, mouth, nose, and salivary glands, is now an epidemic with 65,000 new cases in the US annually [1], whose treatment is, as in many other types of cancers, a dynamic and complex process. This therapy process involves making multiple, patient-specific treatment decisions, to maximize efficacy---e.g., reduction in tumor size, time of local region control, and survival time, while minimizing side effects [2,3,4]. For example, a specific patient may undergo radiotherapy alone (RT), radiotherapy with concurrent chemotherapy (CC), or induction chemotherapy (IC) [5].…”
Section: Introductionmentioning
confidence: 99%
“…Current predictive systems use a staging system based on the size and number of nodal tumors, but miss more nuanced predictions about how the different patterns of nodal spread may affect toxicity outcomes [14,35]. No prior machine learning methods correctly handle this type of spatial data, due to a lack of spatial similarity measures [12,18].…”
Section: Introductionmentioning
confidence: 99%